<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0002723"><a href="http://purl.obolibrary.org/obo/MONDO_0002723">MONDO:0002723</a></h3>
<p><strong>Label:</strong> cutaneous mastocytosis (disease)</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0019316">MONDO:0019316</a> (Maculopapular cutaneous mastocytosis),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_79457">Orphanet:79457</a>, <a href="http://purl.obolibrary.org/obo/OMIM_154800">OMIM:154800</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0007400">HP:0007400</a> (Irregular hyperpigmentation) and <a href="http://purl.obolibrary.org/obo/HP_0200151">HP:0200151</a> (Cutaneous mastocytosis) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001034">HP:0001034</a> (Hypermelanotic macule) and <a href="http://purl.obolibrary.org/obo/HP_0200151">HP:0200151</a> (Cutaneous mastocytosis) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000953">HP:0000953</a> (Hyperpigmentation of the skin) and <a href="http://purl.obolibrary.org/obo/HP_0200151">HP:0200151</a> (Cutaneous mastocytosis) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0007400">HP:0007400</a> (Irregular hyperpigmentation) and <a href="http://purl.obolibrary.org/obo/HP_0012733">HP:0012733</a> (Macule) and <a href="http://purl.obolibrary.org/obo/HP_0200151">HP:0200151</a> (Cutaneous mastocytosis) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0007400">HP:0007400</a> (Irregular hyperpigmentation) and <a href="http://purl.obolibrary.org/obo/HP_0011355">HP:0011355</a> (Localized skin lesion) and <a href="http://purl.obolibrary.org/obo/HP_0200151">HP:0200151</a> (Cutaneous mastocytosis) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001034">HP:0001034</a> (Hypermelanotic macule) and <a href="http://purl.obolibrary.org/obo/HP_0011354">HP:0011354</a> (Generalized abnormality of skin) and <a href="http://purl.obolibrary.org/obo/HP_0200151">HP:0200151</a> (Cutaneous mastocytosis) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001034">HP:0001034</a> (Hypermelanotic macule) and <a href="http://purl.obolibrary.org/obo/HP_0011276">HP:0011276</a> (Vascular skin abnormality) and <a href="http://purl.obolibrary.org/obo/HP_0200151">HP:0200151</a> (Cutaneous mastocytosis) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001034">HP:0001034</a> (Hypermelanotic macule) and <a href="http://purl.obolibrary.org/obo/HP_0002597">HP:0002597</a> (Abnormality of the vasculature) and <a href="http://purl.obolibrary.org/obo/HP_0200151">HP:0200151</a> (Cutaneous mastocytosis) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001034">HP:0001034</a> (Hypermelanotic macule) and <a href="http://purl.obolibrary.org/obo/HP_0001626">HP:0001626</a> (Abnormality of the cardiovascular system) and <a href="http://purl.obolibrary.org/obo/HP_0200151">HP:0200151</a> (Cutaneous mastocytosis) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001009">HP:0001009</a> (Telangiectasia) and <a href="http://purl.obolibrary.org/obo/HP_0007400">HP:0007400</a> (Irregular hyperpigmentation) and <a href="http://purl.obolibrary.org/obo/HP_0200151">HP:0200151</a> (Cutaneous mastocytosis) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001009">HP:0001009</a> (Telangiectasia) and <a href="http://purl.obolibrary.org/obo/HP_0001034">HP:0001034</a> (Hypermelanotic macule) and <a href="http://purl.obolibrary.org/obo/HP_0200151">HP:0200151</a> (Cutaneous mastocytosis) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000953">HP:0000953</a> (Hyperpigmentation of the skin) and <a href="http://purl.obolibrary.org/obo/HP_0012733">HP:0012733</a> (Macule) and <a href="http://purl.obolibrary.org/obo/HP_0200151">HP:0200151</a> (Cutaneous mastocytosis) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000953">HP:0000953</a> (Hyperpigmentation of the skin) and <a href="http://purl.obolibrary.org/obo/HP_0011355">HP:0011355</a> (Localized skin lesion) and <a href="http://purl.obolibrary.org/obo/HP_0200151">HP:0200151</a> (Cutaneous mastocytosis) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000953">HP:0000953</a> (Hyperpigmentation of the skin) and <a href="http://purl.obolibrary.org/obo/HP_0011276">HP:0011276</a> (Vascular skin abnormality) and <a href="http://purl.obolibrary.org/obo/HP_0200151">HP:0200151</a> (Cutaneous mastocytosis) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000953">HP:0000953</a> (Hyperpigmentation of the skin) and <a href="http://purl.obolibrary.org/obo/HP_0001009">HP:0001009</a> (Telangiectasia) and <a href="http://purl.obolibrary.org/obo/HP_0200151">HP:0200151</a> (Cutaneous mastocytosis) 100.00%</li>
</ul>
</body>
</html>
